Resveratrol treatment results in activation of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) by SIRT1, which prevents development of diet-induced obesity and insulin resistance [137]. This evidence concerns the gene PPARGC1A and Insulin resistance.